• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Enact Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    4/30/25 4:23:37 PM ET
    $ACT
    Specialty Insurers
    Finance
    Get the next $ACT alert in real time by email
    act-20250430
    0001823529FALSE00018235292025-04-302025-04-30

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of report (Date of earliest event reported): April 30, 2025


    Enact Holdings, Inc.
    (Exact name of registrant as specified in its charter)


    Delaware
    001-40399
    46-1579166
    (State or other Jurisdiction of(Commission(IRS Employer
    Incorporation)File Number)Identification No.)

    8325 Six Forks Road
    Raleigh, North Carolina 27615
    (919) 846-4100
    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)


    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common stock, par value $0.01 per shareACTThe Nasdaq Stock Market


    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 2.02Results of Operations and Financial Condition.
    On April 30, 2025, Enact Holdings, Inc. (the “Company”) issued (1) a press release announcing its financial results for the quarter ended March 31, 2025, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference, and (2) a financial supplement for the quarter ended March 31, 2025, a copy of which is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

    The information contained in Item 2.02 of this Current Report on Form 8-K (including Exhibits 99.1 and 99.2) is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. The information contained in Item 2.02 of this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

    Item 8.01Other Events.
    On April 30, 2025, we announced that the Board of Directors of the Company has approved authorization of a share repurchase program of up to $350 million of the Company’s outstanding shares of common stock. We also announced an increase of our quarterly dividend to $0.21 per common share. This quarter’s dividend will be payable on June 11, 2025, to shareholders of record on May 19, 2025. A copy of the related press release is furnished as Exhibit 99.3 to this Current Report on Form 8-K.

    Item 9.01Financial Statements and Exhibits.
    The following materials are furnished as exhibits to this Current Report on Form 8-K:

    Exhibit
    Number
      
    99.1
      
    Press Release dated April 30, 2025 - Financial results
    99.2
      
    Financial Supplement for the quarter ended March 31, 2025
    99.3
    Press Release dated April 30, 2025 - Share repurchase program and dividend increase
    104  Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document)


    2



    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Enact Holdings, Inc.
    By:/s/ Hardin Dean Mitchell
      Name:Hardin Dean Mitchell
      Title:Executive Vice President, Chief Financial Officer and Treasurer
    Dated: April 30, 2025  

    3

    Get the next $ACT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ACT

    DatePrice TargetRatingAnalyst
    5/5/2025$39.00Outperform → Mkt Perform
    Keefe Bruyette
    12/6/2023$29.00Neutral
    UBS
    11/13/2023$30.00Neutral → Buy
    BofA Securities
    5/9/2023$25.00 → $27.00Underperform → Neutral
    BofA Securities
    2/8/2023$25.00 → $26.50Mkt Perform → Outperform
    Keefe Bruyette
    1/9/2023$24.50Neutral → Underperform
    Credit Suisse
    9/6/2022$27.00Overweight → Neutral
    JP Morgan
    8/18/2022$25.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $ACT
    SEC Filings

    See more
    • SEC Form 144 filed by Enact Holdings Inc.

      144 - Enact Holdings, Inc. (0001823529) (Subject)

      6/4/25 4:13:15 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Enact Holdings Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Enact Holdings, Inc. (0001823529) (Filer)

      5/19/25 4:03:07 PM ET
      $ACT
      Specialty Insurers
      Finance
    • SEC Form 10-Q filed by Enact Holdings Inc.

      10-Q - Enact Holdings, Inc. (0001823529) (Filer)

      5/2/25 4:01:56 PM ET
      $ACT
      Specialty Insurers
      Finance

    $ACT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Genworth Financial Announces Results of Annual Meeting

      Genworth Financial, Inc. (NYSE:GNW) announced the election of all ten director nominees at its 2025 annual meeting of stockholders today. The board members re-elected were G. Kent Conrad, Karen E. Dyson, Jill R. Goodman, Melina E. Higgins, Thomas J. McInerney, Howard D. Mills, III, Robert P. Restrepo Jr., Elaine A. Sarsynski, Ramsey D. Smith, and Steven C. Van Wyk. At the annual meeting, stockholders also approved the advisory vote on named executive officer compensation and the 2025 Omnibus Incentive Plan. In addition, stockholders ratified the selection of KPMG LLP as Genworth's independent registered public accounting firm for 2025. In addition, stockholders approved an amendment to th

      5/22/25 1:32:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Enact Reports First Quarter 2025 Results

      GAAP Net Income of $166 million, or $1.08 per diluted share Adjusted Operating Income of $169 million, or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion, a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97 RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the first quarter of 2025. "We had a strong start to 2025 and continue to make progress against our priorities," stated Rohit Gupta, President a

      4/30/25 4:20:32 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance

    $ACT
    Financials

    Live finance-specific insights

    See more
    • Enact Reports First Quarter 2025 Results

      GAAP Net Income of $166 million, or $1.08 per diluted share Adjusted Operating Income of $169 million, or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion, a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97 RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced financial results for the first quarter of 2025. "We had a strong start to 2025 and continue to make progress against our priorities," stated Rohit Gupta, President a

      4/30/25 4:20:32 PM ET
      $ACT
      Specialty Insurers
      Finance
    • Genworth Financial Announces First Quarter 2025 Results

      Strategic Highlights Executed $45M in share repurchases at an average price of $6.91 per share; $590M program-to-date through March 31, 2025 at an average price of $5.73 per share Continued progress on the LTC1 multi-year rate action plan with $24M of gross incremental premium approvals; approximately $31.3B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Strong progress made towards the expansion of the CareScout Quality Network, growing coverage to 90% of the aged 65-plus census population in the United States and delivered 576 matches in the first quarter Financial Highlights Net income2 of $54M, or $0.13 per diluted share, and adjusted operati

      4/30/25 4:15:00 PM ET
      $ACT
      $GNW
      Specialty Insurers
      Finance
      Life Insurance
    • Enact Announces 14% Increase to Quarterly Dividend and New $350 Million Share Repurchase Program

      RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) announced that its Board of Directors declared a quarterly dividend of $0.21 per common share, an increase of 14% from the prior quarter's dividend. This dividend will be payable on June 11, 2025, to shareholders of record on May 19, 2025. Additionally, Enact's Board of Directors authorized a new share repurchase program under which the company may purchase up to $350 million of its common stock. The new share repurchase authorization is in addition to the company's current $250 million share repurchase program, of which $6 million remains as of April 25, 2025. "Our increased dividend and new share re

      4/30/25 4:10:00 PM ET
      $ACT
      Specialty Insurers
      Finance